Questa Capital

Questa Capital is a venture growth equity firm exclusively dedicated to the healthcare industry. The firm partners with exceptional teams building the next generation of breakout healthcare companies, investing in change that elevates patient experiences, reduces costs, and improves patient health. Questa Capital focuses its investments across healthcare services, healthcare technology, and medical devices sectors, seeking out disruptive, technology-enabled business models that improve patient lives and streamline market inefficiencies.

Founded in 2016, Questa Capital was established by Ryan Drant to back outstanding leaders in their mission to transform the healthcare landscape. Ryan Drant, along with co-founders Bradley Sloan and Shawn Conway, brought extensive experience from leading investment firms such as New Enterprise Associates (NEA) and Parthenon Capital. The firm's founding vision was to provide sound advice and unwavering support to their portfolio companies, leveraging their collective decades of experience in healthcare investment and operations.

Questa Capital maintains a robust portfolio of companies that are innovating across various healthcare segments. Notable investments include Avive, which aims to increase cardiac arrest survival rates; Bicycle Health, expanding access to opioid recovery via telemedicine; Calyxo, revolutionizing kidney stone care; ClaritasRx, optimizing biopharma operational success; Cortica, advancing neurological care for children; and DispatchHealth, redefining on-call in-home medical care. Other key investments feature companies like EnsoData, Ossio, ACTO, EPIX Therapeutics, and Medrio, all contributing to advancements in healthcare delivery and technology.

The firm's team comprises seasoned professionals with deep sector expertise. Ryan Drant, a four-time Forbes Midas List honoree, has been actively investing in healthcare since 1996. Bradley Sloan brings over 25 years of healthcare industry and investment experience, while Shawn Conway, as COO, leads day-to-day operations with extensive experience in emerging growth companies. The team's collective experience and disciplined, research-driven approach enable them to identify innovative companies and provide strategic guidance to accelerate their growth and achieve market leadership.